<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: brand</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'brand'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22brand%22&t=%22brand%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:03:11 +0100</lastBuildDate>
        <item>
            <title>Connect Emotionally to Boost Sales</title>
            <link>http://www.medworm.com/index.php?rid=5181907&amp;cid=t_131467_109_f&amp;fid=34761&amp;url=http%3A%2F%2Ffeeds.feedblitz.com%2F%7E%2F27005966%2F0%2Fneuromarketing%7EConnect-Emotionally-to-Boost-Sales.htm</link>
            <description>Does your brand or business have an emotional connection with at least some of its customers? If so, that&amp;#8217;s a very good thing. A new study of retail chains showed that while just one in five consumers felt they had an emotional connection to a retailer, those that did were far more valuable as customers [...]
      CommentsGood summary thanks. And a good link back to the earlier post ... by Brendon B ClarkGreat article. Just goes to show how powerful building an ... by Aman Basanti &amp;#124; Age of MarketingPlus 2 more...Related StoriesLove BrandingSales Secret: The Best Time to CloseThe Rivalry in Your Customer&amp;#8217;s Brain (Source: Neuromarketing)</description>
            <author>Neuromarketing</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5181907</comments>
            <pubDate>Thu, 01 Sep 2011 12:36:13 +0100</pubDate>
            <guid isPermaLink="false">5181907</guid>        </item>
        <item>
            <title>Russell Brand on Amy Winehouse</title>
            <link>http://www.medworm.com/index.php?rid=5086562&amp;cid=t_131467_151_f&amp;fid=35818&amp;url=http%3A%2F%2Frecoveryissexy.com%2Frussell-brand-on-amy-winehouse%2F</link>
            <description>When you love someone who suffers from the disease of addiction you await the phone call. There will be a phone call. The sincere hope is that the call will be from the addict themselves, telling you they&amp;#8217;ve had enough, that they&amp;#8217;re ready to stop, ready to try something new. Of course though, you fear the other call, the sad nocturnal chime from a friend or relative telling you it&amp;#8217;s too late, she&amp;#8217;s gone.
Frustratingly it&amp;#8217;s not a call you can ever make it must be received. It is impossible to intervene.
Russell Brand on Amy Winehouse: &amp;#8216;We have lost a beautiful, talented woman&amp;#8217; | Music | guardian.co.uk.
:Ever Wondered Why?Women&amp;rsquo;s Sexual AddictionWomen&amp;#8217;s Sexual Addiction30 Natural HighsI Finally Listened to Their Stories (Source: Recovery ...</description>
            <author>Recovery Is Sexy.com</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5086562</comments>
            <pubDate>Sun, 31 Jul 2011 20:45:39 +0100</pubDate>
            <guid isPermaLink="false">5086562</guid>        </item>
        <item>
            <title>#ePharma West: Analytics. When, where and how?</title>
            <link>http://www.medworm.com/index.php?rid=5140259&amp;cid=t_131467_147_f&amp;fid=39273&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FePharmaSummit%2F%7E3%2Fql2N04t8GRU%2Fepharma-west-analytics-when-where-and.html</link>
            <description>Measuring Digital Marketing Toward Supporting Patient Adherence &amp; Consumer Education
Peter Frishauf, Non-executive Chairman of the Board, Crossix Solutions Inc
Jeremy Mittler, Analytics Services Director, Crossix Solutions Inc



Frishauf

Crossix Solutions Inc helps match patient/consumer data to prescription data to help link effective medicine. This company innovates for Pharma in the digital space with patient adherence. Three out of four patients aren’t adherent which results in 125,000 deaths a year. Over $310 billion dollars a year is the cost of non-adherence. Digital is playing an increasing role in improving adherence. How can you measure that your adherence campaigns are successful?




Reaching Existing Patients: 





Direct to Consumer efforts leads to 51% existing pati...</description>
            <author>ePharma Summit</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5140259</comments>
            <pubDate>Tue, 26 Jul 2011 21:05:00 +0100</pubDate>
            <guid isPermaLink="false">5140259</guid>        </item>
        <item>
            <title>Expectation Affects Our Food Likes and Dislikes</title>
            <link>http://www.medworm.com/index.php?rid=5036278&amp;cid=t_131467_109_f&amp;fid=34750&amp;url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2011%2F07%2F16%2Fexpectation-affects-our-food-likes-and-dislikes%2F</link>
            <description>What is expectation assimilation?
It&amp;#8217;s the notion that our taste perceptions are biased by our imagination, and if you expect a food to taste good it will.  However, expectation assimilation also works in the opposite direction.  If you expect a food to taste unpleasant it will (Wansink, 2006).
At a cafeteria in Urbana, Illinois, 175 people were given a free brownie dusted with powdered sugar (Wansink, 2006).  They were told the brownie was a new dessert that may be added to the menu.  They were asked how they liked the flavor and how much they would pay for it.   All of the brownies were the same size and had the same ingredients.  However, the brownies were served on a china plate, on a paper plate or on a paper napkin.
Those who received the brownie on a china plate said t...</description>
            <author>World of Psychology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5036278</comments>
            <pubDate>Sat, 16 Jul 2011 10:28:53 +0100</pubDate>
            <guid isPermaLink="false">5036278</guid>        </item>
        <item>
            <title>Study: TV Branding Beats Online</title>
            <link>http://www.medworm.com/index.php?rid=4813367&amp;cid=t_131467_109_f&amp;fid=34761&amp;url=http%3A%2F%2Ffeeds.feedblitz.com%2F%7E%2F25864520%2F0%2Fneuromarketing%7EStudy-TV-Branding-Beats-Online.htm</link>
            <description>Television ads are far more potent than online ads for viewer engagement and brand resonance, according to a new study by Fox Broadcasting and neuromarketing firm Innerscope Research. According to information released by Innerscope, &amp;#8220;television ads across the spectrum of familiarity evoked 38x more emotional engagement, a combination of intensity of and time spent in [...]
      CommentsI'm sure that this will change within a few years by Frugal LivingMatt, the online ads are described only as “rich media” – ... by Roger DooleyPlus 3 more...Related StoriesNeuromarketing Study at OxfordWalmart CEO Confirms Payday Timing EffectSimple Slogans Double Sales (Source: Neuromarketing)</description>
            <author>Neuromarketing</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4813367</comments>
            <pubDate>Wed, 11 May 2011 12:16:34 +0100</pubDate>
            <guid isPermaLink="false">4813367</guid>        </item>
        <item>
            <title>Best of Our Blogs: May 10, 2011</title>
            <link>http://www.medworm.com/index.php?rid=4803232&amp;cid=t_131467_109_f&amp;fid=34750&amp;url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2011%2F05%2F10%2Fbest-of-our-blogs-may-10-2011%2F</link>
            <description>A friend once asked me how to handle her disobedient son. She was going through a divorce and her son was taking out his pain, confusion and anger about his parent&amp;#8217;s relationship on her. She wanted to distance herself from him because he was being so hurtful. But I told her to reconsider.
My mom and I have an imperfectly perfect relationship. We&amp;#8217;re close. But we rarely see eye to eye on anything. We&amp;#8217;re as different as we are alike. I like to find good deals. She loves brand names. She chose a traditional 9 to 5 job. I went the opposite way and designed my own career. At the same time, we&amp;#8217;re both sensitive and emotional, which is the perfect recipe for personal and sometimes heated debates.
But I have to say one thing. I grew up as a child of divorce too. And I told ...</description>
            <author>World of Psychology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4803232</comments>
            <pubDate>Tue, 10 May 2011 11:50:07 +0100</pubDate>
            <guid isPermaLink="false">4803232</guid>        </item>
        <item>
            <title>EU Trade Deal Could Cost Canada $3B For Drugs</title>
            <link>http://www.medworm.com/index.php?rid=4446032&amp;cid=t_131467_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FqZDR45Q5V5o%2F</link>
            <description>A trade deal being negotiated between Canada and the European Union could cost Canadians another $2.8 billion annually in drug costs - notably, by delaying the availability of lower-cost generics in Canada by about 3.5 years - if certain proposals are cemented, according to a new report commissioned by generic drugmakers.
During the talks, the EU has sought various changes in Canadian laws and regulations governing intellectual property concerning brand-name meds. These include extending the term of patent protection by up to five years if drugs are bogged down in the regulatory approval process; lengthening the period of data exclusivity from eight years to 10 years or more; and strengthening notice of compliance regulations by adding an appeals process.
The upshot is that Canadian payers...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4446032</comments>
            <pubDate>Mon, 07 Feb 2011 16:24:19 +0100</pubDate>
            <guid isPermaLink="false">4446032</guid>        </item>
        <item>
            <title>Most Desired Brands: a Neuromarketing Ranking</title>
            <link>http://www.medworm.com/index.php?rid=4429061&amp;cid=t_131467_109_f&amp;fid=34761&amp;url=http%3A%2F%2Ffeeds.feedblitz.com%2F%7E%2F23999479%2F0%2Fneuromarketing%7EMost-Desired-Brands-a-Neuromarketing-Ranking.htm</link>
            <description>Buyology Inc. has released its &amp;#8220;first annual&amp;#8221; list of the most desired brands in the U.S. Of interest to Neuromarketing readers is that the list is based on the firm&amp;#8217;s Neurotypes brand profiling technique, which uses a combination of EEG brain monitoring and eye-tracking data. First, here are Buyology&amp;#8217;s top brands: Top 20 Most Desired [...]
      CommentsI find the results in the matrix even more curious. Like Apple ... by DeniseGood point, Cindy. I'm surprised American Express didn't appear ... by Roger DooleyPlus 4 more...Related StoriesMost Immersive Outdoor Ad EverBrandwashing?Impossible Branding? (Source: Neuromarketing)</description>
            <author>Neuromarketing</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4429061</comments>
            <pubDate>Wed, 02 Feb 2011 14:18:28 +0100</pubDate>
            <guid isPermaLink="false">4429061</guid>        </item>
        <item>
            <title>How To Be More Interesting Than You Ever Thought Possible (And Let Everyone Know It!)</title>
            <link>http://www.medworm.com/index.php?rid=4249269&amp;cid=t_131467_180_f&amp;fid=38612&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fpickthebrain%2FLYVv%2F%7E3%2F3SaA-z7EYS8%2F</link>
            <description>Why should people remember you?
What makes you stand out in a crowd?
What makes you different from other people in your field?
How can others relate to you?
If you can&amp;#8217;t answer those questions, perhaps it&amp;#8217;s time to think about how you brand yourself. Branding is the process of attributing a characteristic, quality, or image to something in order to associate an item with those qualities. For instance, think of Disney, and you think wholesome, family entertainment, right? It&amp;#8217;s what the company is known for. This is not an accident, but rather, by design.
Branding isn&amp;#8217;t just for companies like Nike, McDonald&amp;#8217;s, and Disney anymore, though. Today&amp;#8217;s entrepreneur realizes that if you want to stand out, you need to brand yourself. Branding is what separates Gar...</description>
            <author>PickTheBrain | Motivation and Self Improvement</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4249269</comments>
            <pubDate>Fri, 10 Dec 2010 16:24:49 +0100</pubDate>
            <guid isPermaLink="false">4249269</guid>        </item>
        <item>
            <title>Winning In The Relationship Era</title>
            <link>http://www.medworm.com/index.php?rid=4220442&amp;cid=t_131467_147_f&amp;fid=39273&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FePharmaSummit%2F%7E3%2FeAbLOY4dt6U%2Fwinning-in-relationship-era.html</link>
            <description>Marketers feel the ground shifting beneath their feet. Health care consumers are more empowered than ever, and as consumers gain unparalleled access to and influence over brands, they form new expectations about brand relationships. They expect us to truly engage with them - and to provide value beyond the pill - by building an experience around the brand that’s not about product branding, but rather about making them and their loved ones healthier. Authenticity and trust will drive their behaviors, not 30-second spots. So, how can business leaders - given the realities of the current regulatory environment - best adapt from a campaign-driven paradigm to an always-on marketing ecosystem? Learn how brands can adapt and win in the “Relationship Era” by building sustainable relationship...</description>
            <author>ePharma Summit</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4220442</comments>
            <pubDate>Wed, 01 Dec 2010 15:52:00 +0100</pubDate>
            <guid isPermaLink="false">4220442</guid>        </item>
        <item>
            <title>Is The Young Pharmaceutical Rep Right?</title>
            <link>http://www.medworm.com/index.php?rid=4159239&amp;cid=t_131467_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Fis-the-young-pharmaceutical-rep-right%2F2010.11.12</link>
            <description>I loved my old status. Perhaps, reveled in it would be a better description. I was a crotchety, generic medicine-only doctor.** Sadly, my status changed today. Dabigatran (brand name Pradaxa) was the culprit.
It was a little nerve racking. I wrote the order, looked at it, thought it out again, talking to myself: &amp;#8220;John, are you sure you don&amp;#8217;t want to do it the old way? [pause to think] No, I am embracing the new.&amp;#8221;  And then, I closed the chart and handed it to the nurse.
&amp;#8220;What&amp;#8217;s that? Pradaxa?&amp;#8221; asked the nurse. &amp;#8220;Stop the Lovenox? You sure?&amp;#8221; My face must have told the story.
Eight days had passed since dabigatran&amp;#8217;s approval. &amp;#8220;That&amp;#8217;s plenty of time to mourn warfarin&amp;#8217;s demise,&amp;#8221; I thought. Enough studies, enough bl...</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4159239</comments>
            <pubDate>Fri, 12 Nov 2010 19:00:00 +0100</pubDate>
            <guid isPermaLink="false">4159239</guid>        </item>
        <item>
            <title>ePharma Summit: Putting the Consumer Back in DTC</title>
            <link>http://www.medworm.com/index.php?rid=3994351&amp;cid=t_131467_150_f&amp;fid=38374&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FePharmaSummit%2F%7E3%2FkzLqJqxxI2s%2Fepharma-summit-putting-consumer-back-in.html</link>
            <description>ePharma Summit 2010 took place this past February in Philadelphia. If you were unable to make it, we will now be presenting a weekly video series featuring all of the sessions from our event. This week Hensley Evans, President,imc² health &amp; wellness, leads a panel discussion with Brent Rose, of Daiichi Sankyo and Ginger Vieira of Diabete Teens titled Putting the Consumer Back in DTC: Five Things Pharma Can Learn From Consumer Brand Marketers.Click here to watch the video. The video is under the &quot;video&quot; portion of the interactive player on the ePharma Summit webpage.ePharma Summit now has a Facebook fan page! Like the ePharma Summit today! (Source: ePharma Summit)</description>
            <author>ePharma Summit</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3994351</comments>
            <pubDate>Tue, 21 Sep 2010 13:00:00 +0100</pubDate>
            <guid isPermaLink="false">3994351</guid>        </item>
        <item>
            <title>Generic Drugs: Not So Cheap</title>
            <link>http://www.medworm.com/index.php?rid=3935799&amp;cid=t_131467_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Fgeneric-drugs-not-so-cheap%2F2010.09.05</link>
            <description>I received the following e-mail from a patient (paraphrased):
Dear Dr. Fisher,
Thank you for trying to switch me from lisinopril to generic losartan (Cozaar) to help me with the irritating cough that has been nagging me since I was placed on lisinopril. I did not pick up my prescription, though. At nearly $200 for a three-month supply, I&amp;#8217;ve decided to live with the cough, since the same amount of lisinopril costs me about $12.
-Ms. Patient
Interesting how the generic drug market for some drugs only marginally discounts prices. Since the companies that make generics did not have to absorb research and development costs, how do they justify the exorbitant prices? Simple: The middlemen still have to get theirs.
-WesMusings of a cardiologist and cardiac electrophysiologist.

			
			*This...</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3935799</comments>
            <pubDate>Sun, 05 Sep 2010 16:00:00 +0100</pubDate>
            <guid isPermaLink="false">3935799</guid>        </item>
        <item>
            <title>Revealed: How Steve Jobs Turns Customers into Fanatics</title>
            <link>http://www.medworm.com/index.php?rid=3942843&amp;cid=t_131467_109_f&amp;fid=34761&amp;url=http%3A%2F%2Ffeeds.feedblitz.com%2F%7E%2F19488038%2F0%2Fneuromarketing%7ERevealed-How-Steve-Jobs-Turns-Customers-into-Fanatics.htm</link>
            <description>Marketers gaze in envy at brands like Apple. The firm that began with the Mac built some of the first home computers [doh, thanks, alert reader!] has turned their customers into legions of fanatical evangelists. But, without a Steve Jobs at the helm, or with fewer resources than Apple, is building that kind [...]
      CommentsHello I stopped reading all the comments (my bad) because the ... by Carole S[...] an online community dedicated to health and well being. ... by Parallel Insights &amp;#187; Blog Archive &amp;#187; The tribal mentality and a brand&amp;#8217;s successPlus 8 more... (Source: Neuromarketing)</description>
            <author>Neuromarketing</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3942843</comments>
            <pubDate>Wed, 25 Aug 2010 15:38:53 +0100</pubDate>
            <guid isPermaLink="false">3942843</guid>        </item>
        <item>
            <title>How Brand-Name Drugmakers Fight Generics</title>
            <link>http://www.medworm.com/index.php?rid=3780565&amp;cid=t_131467_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FhUrAUHm71Bo%2F</link>
            <description>With all those patent expirations under way, brand-name drugmakers, of course, are desperate to wring as much money as possible out of their products. So how do they counter the generic onslaught? There are several tricks and every company employs multiple strategies, although patent challenges were the most popular choice over the past three years, according to a new survey.
Patent litigation, in fact, was pursued by 60 percent of those queried by Cutting Edge Information, followed closely by defensive pricing, which was popular among 57 percent of the respondents. Half of those surveyed also like to concoct new formulations or a next-generation drug, with new indications clocking in at 45 percent. Only 29 percent pointed to an authorized generic or generics subsidiary.
Over the next thre...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3780565</comments>
            <pubDate>Thu, 22 Jul 2010 14:42:20 +0100</pubDate>
            <guid isPermaLink="false">3780565</guid>        </item>
        <item>
            <title>Women’s Sexual Addiction</title>
            <link>http://www.medworm.com/index.php?rid=3758115&amp;cid=t_131467_151_f&amp;fid=35818&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FRecoveryIsSexycom%2F%7E3%2F6PcH19rouAY%2F</link>
            <description>Sex addiction: not just for men
Any time I met a guy who didn’t respond to me sexually, it would make me determined to have him,” confesses Valerie, 35, a human-resources manager in the City. “It became a challenge, a game, regardless of whether he was married or with someone. The lowest point came when I tried to seduce my best friend’s fiancé. I couldn’t bear the fact that, when they were together, he wouldn’t so much as look at me. It was an itch I had to scratch.”
“Sex addict” is the last phrase that would come to mind if you met the demure and sober-suited Valerie. Yet she is in 12-step recovery for that very issue. “Everyone used to tell me how lucky I was, as I could get any man I wanted. I’m quite a competitive person and it was important for me to know that,...</description>
            <author>Recovery Is Sexy.com</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3758115</comments>
            <pubDate>Wed, 14 Jul 2010 15:47:01 +0100</pubDate>
            <guid isPermaLink="false">3758115</guid>        </item>
        <item>
            <title>Drug Ads: Consumers And Doctors Are Tuning Them Out</title>
            <link>http://www.medworm.com/index.php?rid=3746741&amp;cid=t_131467_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Fdrug-ads-consumers-and-doctors-are-tuning-them-out%2F2010.07.12</link>
            <description>How effective is direct-to-consumer drug advertising? Some think that drug ads should be banned altogether, saying that it encourages patients to ask their doctors for expensive, brand name prescription drugs. It turns out their fears may be overblown.
NPR’s Shots blogs about a recent study looking at the effectiveness of these ads. The numbers, for the pharmaceutical companies anyways, are not encouraging. (more&amp;#8230;)

			
			*This blog post was originally published at KevinMD.com* (Source: Better Health)</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3746741</comments>
            <pubDate>Mon, 12 Jul 2010 12:00:19 +0100</pubDate>
            <guid isPermaLink="false">3746741</guid>        </item>
        <item>
            <title>10 Tips for Beginner Hospital Bloggers</title>
            <link>http://www.medworm.com/index.php?rid=3743720&amp;cid=t_131467_147_f&amp;fid=39202&amp;url=http%3A%2F%2Fnicolaziady.wordpress.com%2F2010%2F07%2F11%2F10-tips-for-beginner-hospital-bloggers%2F</link>
            <description>When I attended the Healthcare New Media conference last month it was evident that hospitals were successfully adopting social networking into their marketing plans. But according to Ed Bennett healthcare marketers are slow to start blogging.
744 Hospitals total
* 344 YouTube Channels
* 530 Facebook pages
* 557 Twitter Accounts
* 96 Blogs
Read more at Found in Cache
Starting a blog can seem overwhelming, but in truth, it&amp;#8217;s one of the simplest ways to build an online community with your patients and physicians. Follow these tips to ensure your blog is positioned for success ::
[1] Define your hospitals goals ::
Before you start a blog it is essential that you define your goals for it. Your blog has a greater chance of success if you know from the beginning what you hope to accomplish....</description>
            <author>Nicola Ziady</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3743720</comments>
            <pubDate>Mon, 12 Jul 2010 04:22:26 +0100</pubDate>
            <guid isPermaLink="false">3743720</guid>        </item>
        <item>
            <title>US And European Prices Aren’t So Different After All</title>
            <link>http://www.medworm.com/index.php?rid=3730097&amp;cid=t_131467_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FG5nOwsBCVO4%2F</link>
            <description>The difference in prices of brand-name meds in the US and Europe are actually modest and declining over time, according to a forthcoming study, possibly undermining claims that higher US prices are needed to fund research and development efforts, The Financial Times reports (UPDATE: registration may be required).
The study, which was conducted by researchers at the London School of Economics, is due to be published in Health Economics, Policy and Law, and concludes that “public prices for branded prescription medicines in the US are comparable to those in key European and other OECD countries.” 
You may recall that PhRMA argues the tightly controlled pricing policies in European countries dampen R&amp;#038;D innovation and investment. But the FT writes that the study confirms data released...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3730097</comments>
            <pubDate>Tue, 06 Jul 2010 13:04:31 +0100</pubDate>
            <guid isPermaLink="false">3730097</guid>        </item>
        <item>
            <title>House Proposal To End Pay-For Delay Generic Deals</title>
            <link>http://www.medworm.com/index.php?rid=3721960&amp;cid=t_131467_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F28WlTkAyHMw%2F</link>
            <description>A proposal to end those controversial &amp;#8216;pay-to-delay&amp;#8217; deals between brand-name and generic drugmakers was passed by the House of Representatives last night as part of a measure to fund wars. Ironic, yes? Or maybe appropriate. In any event, the bill now goes to the Senate, Bloomberg News reports.
Under the proposal, drugmakers could be fined if the Federal Trade Commission or the courts determine they struck deals to preserve a brand-name drug patent by delaying introduction of a lower-priced generic equivalent (see page 74). This is “just another signal of the growing support in Congress for ending this unconscionable behavior by some pharmaceutical companies,” FTC chairman Jon Leibowitz tells the news service. 
The FTC, you may recall, has made a mission of ending these dea...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3721960</comments>
            <pubDate>Fri, 02 Jul 2010 12:55:23 +0100</pubDate>
            <guid isPermaLink="false">3721960</guid>        </item>
        <item>
            <title>A Tight Brand Focus</title>
            <link>http://www.medworm.com/index.php?rid=3798621&amp;cid=t_131467_109_f&amp;fid=34761&amp;url=http%3A%2F%2Ffeeds.feedblitz.com%2F%7E%2F15508238%2F1mr3x3%2Fneuromarketing%7EA-Tight-Brand-Focus.htm</link>
            <description>Most companies think about extending their brand to maximize their exposure and value. That&amp;#8217;s why we have HUMMER cologne (at least while the vehicles were in production), and Purple Oreos. In many cases, these brand extensions makes sense: if a brand&amp;#8217;s primary product has entered a phase of slow or low growth, extending [...]
      CommentsEnjoyed your post! I agree, extending a business brand can be ... by VerndaleMaking sure that extending a businesses brand doesnt dilute ... by B @ logos coachingAgreed! Sometimes the extension can do far more harm than good. ... by Eric Helzer (Source: Neuromarketing)</description>
            <author>Neuromarketing</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3798621</comments>
            <pubDate>Thu, 01 Jul 2010 14:37:46 +0100</pubDate>
            <guid isPermaLink="false">3798621</guid>        </item>
        <item>
            <title>Unconscious Branding: Who Needs Facts?</title>
            <link>http://www.medworm.com/index.php?rid=3656849&amp;cid=t_131467_109_f&amp;fid=34761&amp;url=http%3A%2F%2Ffeeds.feedblitz.com%2F%7E%2F13514676%2F1hb0i1%2Fneuromarketing%7EUnconscious-Branding-Who-Needs-Facts.htm</link>
            <description>Few doubt that branding messages can be powerful, but new research shows that even when consumers don&amp;#8217;t recall the specific message, their preferences can be shaped to the point where they reject new information that conflicts with their stored brand association.
&amp;#8220;I don&amp;#8217;t know why I like it&amp;#8221;
Melanie Dempsey (Ryerson University) and Andrew A. Mitchell (University [...]
      CommentsRoger, Great post. Shazam!!! Got to get those favorable ... by SteveThanks for this Roger. Subconsciously I knew this all along of ... by Dennis Van Staalduinen (Source: Neuromarketing)</description>
            <author>Neuromarketing</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3656849</comments>
            <pubDate>Fri, 21 May 2010 12:09:39 +0100</pubDate>
            <guid isPermaLink="false">3656849</guid>        </item>
        <item>
            <title>Buying the Counterfeit May Cost You More Than You Thought</title>
            <link>http://www.medworm.com/index.php?rid=3511587&amp;cid=t_131467_109_f&amp;fid=34750&amp;url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2010%2F04%2F28%2Fbuying-the-counterfeit-may-cost-you-more-than-you-thought%2F</link>
            <description>We want to look good but can&amp;#8217;t always afford designer-name sunglasses. So what do some of us do? We buy a cheap knockoff or &amp;#8220;gray market&amp;#8221; item that looks just like the designer brand name, without the designer price. It signals to others &amp;#8212; we hope &amp;#8212; that we&amp;#8217;re as cool and &amp;#8220;with it&amp;#8221; as anyone else (even when we can&amp;#8217;t afford to be).
But we may be getting more than we thought.
We are all aware of the potential consequences of buying fake, counterfeit items on the street &amp;#8212; you might get a shabby knockoff or pay too much for it. But outside of questionable quality of such goods, there may be others costs you&amp;#8217;re not even aware of. Buying counterfeit goods may actually make us feel less authentic &amp;#8212; just like the cheap, knocko...</description>
            <author>World of Psychology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3511587</comments>
            <pubDate>Wed, 28 Apr 2010 09:30:59 +0100</pubDate>
            <guid isPermaLink="false">3511587</guid>        </item>
        <item>
            <title>Complimentary Web Seminar tomorrow: Leverage Facebook to Improve Brand Awareness and Promote Patient Advocacy</title>
            <link>http://www.medworm.com/index.php?rid=3395369&amp;cid=t_131467_150_f&amp;fid=38374&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FePharmaSummit%2F%7E3%2FUTv4Q9AsIBA%2Fcomplimentary-web-seminar-tomorrow.html</link>
            <description>(Source: ePharma Summit)</description>
            <author>ePharma Summit</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3395369</comments>
            <pubDate>Tue, 23 Mar 2010 14:02:00 +0100</pubDate>
            <guid isPermaLink="false">3395369</guid>        </item>
        <item>
            <title>Complimentary Web Seminar: Leverage Facebook to Improve Brand Awareness and Promote Patient Advocacy</title>
            <link>http://www.medworm.com/index.php?rid=3346725&amp;cid=t_131467_150_f&amp;fid=38374&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FePharmaSummit%2F%7E3%2F6PNIjeAC2iY%2Fcomplimentary-web-seminar-leverage.html</link>
            <description>(Source: ePharma Summit)</description>
            <author>ePharma Summit</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3346725</comments>
            <pubDate>Mon, 08 Mar 2010 19:34:00 +0100</pubDate>
            <guid isPermaLink="false">3346725</guid>        </item>
        <item>
            <title>Trade-Off by Kevin Maney</title>
            <link>http://www.medworm.com/index.php?rid=3189212&amp;cid=t_131467_109_f&amp;fid=34761&amp;url=http%3A%2F%2Ffeeds.feedblitz.com%2F%7E%2F3856997%2F10l7iq%2Fneuromarketing%7ETradeOff-by-Kevin-Maney.htm</link>
            <description>Marketable business ideas often have two key characteristics: simplicity, and a way of categorizing products, brands, or companies. The Boston Matrix, for example, launched armies of strategy consultants who neatly fit businesses into buckets labeled, &quot;cash cow,&quot; &quot;star,&quot; &quot;dog,&quot; etc. Kevin Maney's book Trade-Off has those characteristics as well.
      CommentsComments (Source: Neuromarketing)</description>
            <author>Neuromarketing</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3189212</comments>
            <pubDate>Mon, 14 Dec 2009 13:37:55 +0100</pubDate>
            <guid isPermaLink="false">3189212</guid>        </item>
        <item>
            <title>Neuromarketing at Microsoft</title>
            <link>http://www.medworm.com/index.php?rid=3189213&amp;cid=t_131467_109_f&amp;fid=34761&amp;url=http%3A%2F%2Ffeeds.feedblitz.com%2F%7E%2F3738963%2F10l7iq%2Fneuromarketing%7ENeuromarketing-at-Microsoft.htm</link>
            <description>Video games and movies are one of the more interesting neuromarketing applications, in that the technology can be applied to not just advertising but the product itself. A new effort by Microsoft and Emsense carries that idea one step further by attempting to compare viewer engagement with advertising across multiple technology platforms, including Xbox [...]
      CommentsI thought that Emsense technology was a kind of single ... by Sergio Monge - Neuromarca: Blog sobre NeuromarketingThis is what I had always suspected. Emsense does NOT do EEG or ... by Qunice HunsickerPlus 2 more... (Source: Neuromarketing)</description>
            <author>Neuromarketing</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3189213</comments>
            <pubDate>Fri, 11 Dec 2009 13:09:41 +0100</pubDate>
            <guid isPermaLink="false">3189213</guid>        </item>
    </channel>
</rss>

